Abstract
Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35% occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 140-147 |
| Number of pages | 8 |
| Journal | Academic Radiology |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1995 |
Fingerprint
Keywords
- contrast media
- liver
- Magnetic resonance imaging
- manganese carbonate nanoparticles
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. / Wisner, Erik R; Merisko-Liversidge, Elaine; Kellar, Kenneth; Katzberg, Richard W; Karpinski, Piotr H.; Amparo, Eugenio G.; Drake, Christiana; Griffey, Stephen M; Brock, John M.
In: Academic Radiology, Vol. 2, No. 2, 1995, p. 140-147.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver
AU - Wisner, Erik R
AU - Merisko-Liversidge, Elaine
AU - Kellar, Kenneth
AU - Katzberg, Richard W
AU - Karpinski, Piotr H.
AU - Amparo, Eugenio G.
AU - Drake, Christiana
AU - Griffey, Stephen M
AU - Brock, John M.
PY - 1995
Y1 - 1995
N2 - Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35% occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.
AB - Rationale and Objectives.: We characterized the physical, biological, and imaging properties of a manganese (Mn) carbonate particle suspension, a contrast agent for hepatic magnetic resonance (MR) imaging. Methods.: Mn carbonate suspensions were produced by controlled precipitation and characterized using light microscopy, transmission electron microscopy, and in vitro relaxivity studies. Efficacy of the agent was studied in normal and tumor-bearing rats using T1-weighted MR imaging. Results.: Following intravenous injection of Mn carbonate particles at doses ranging from 10 to 100 μmol Mn/kg, peak hepatic contrast enhancement of approximately 35% occurred from about 125 min until the termination of the MR imaging studies that varied from 125 to 305 min. Lesion conspicuity was increased because of relative intensity differences between normal liver and tumor. Data also showed that Mn carbonate particle dissolved on delivery to the liver, allowing Mn to interact with intrahepatic macromolecular complexes to provide positive contrast enhancement. Conclusion.: Mn carbonate particles produce significant and sustained hepatic enhancement and should improve detection of small or isointense liver lesions.
KW - contrast media
KW - liver
KW - Magnetic resonance imaging
KW - manganese carbonate nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=0029240601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029240601&partnerID=8YFLogxK
U2 - 10.1016/S1076-6332(05)80149-7
DO - 10.1016/S1076-6332(05)80149-7
M3 - Article
VL - 2
SP - 140
EP - 147
JO - Academic Radiology
JF - Academic Radiology
SN - 1076-6332
IS - 2
ER -